REGEN
Get REGENGet Now
LibraryToolsNotesBlogFAQ

GHRP-6 Dosage and Protocols

GHRP-6 dosage protocols reported in published research, plus reconstitution and storage.

RE
Compiled from published research · Last updated 2026-08-18T00:00:00.000Z

Research Protocol Doses Reported in Published Literature

Research Disclaimer: Doses reported below are from published preclinical research protocols. GHRP-6 is not approved for human use by the FDA or any regulatory agency. This information is provided for research reference only and does not constitute a dosing recommendation. All doses above are reported from published research protocols using laboratory subjects. Refer to the cited studies in the Research Studies section above for original source data.

Reported protocol doses

Standard dose100–300 mcg
Frequency1-3x daily
Routessubcutaneous

Reconstitution

A 5mg vial with 2.5mL of bacteriostatic water is the pairing reported most often. 5mg vial + 2.5mL bacteriostatic water = 2000mcg/mL. A 100mcg dose is 0.05mL (5 units).

Work out your own concentration with the reconstitution calculator.

Doses shown are those reported in published research, not a recommendation.

References

  1. GHRP-6 and the discovery of the ghrelin receptor · Bowers CY · 2012
  2. Bowers CY, et al. On the in vitro and in vivo activity of a new synthetic hexapeptide that acts on the pituitary to specifically release growth hormone. Endocrinology. 1984;114(5):1537-1545. · Bowers CY, Momany FA, Reynolds GA, Hong A · 1984
  3. Acute dexamethasone administration enhances GH responsiveness to GH releasing peptide-6 (GHRP-6) in man. · Pinto AC, Finamor FE Jr, Lengyel AM · 1999
  4. Howard AD, et al. A receptor in pituitary and hypothalamus that functions in growth hormone release. Science. 1996;273(5277):974-977. · Howard AD, Feighner SD, Cully DF, Arena JP, Liberator PA, Rosenblum CI, Hamelin M, Hreniuk DL, Palyha OC, Anderson J, Paress PS, Diaz C, Chou M, Liu KK, McKee KK, Pong SS, Chaung LY, Elbrecht A, Dashkevicz M, Heavens R, Rigby M, Sirinathsinghji DJ, Dean DC, Melillo DG, Patchett AA, Nargund R, Griffin PR, DeMartino JA, Gupta SK, Schaeffer JM, Smith RG, Van der Ploeg LH · 1996
  5. Growth hormone response to GHRH, GHRP-6 and GHRH + GHRP-6 in patients with polycystic ovary syndrome. · Micić D, Kendereski A, Popović V et al. · 1996
  6. Synthetic Growth Hormone-Releasing Peptides (GHRPs) - NIH · Berlanga-Acosta J, Abreu-Cruz A, Herrera DGB, Mendoza-Marí Y, Rodríguez-Ulloa A, García-Ojalvo A, Falcón-Cama V, Hernández-Bernal F, Beichen Q, Guillén-Nieto G · 2017
All GHRP-6 sections

CJC-1295 (no-DAC)

growth & GHCgrade

The short-acting form of CJC-1295 (Mod GRF 1-29): a sharp, pulsatile GH release that closely mimics natural rhythm.

hCG (Human Chorionic Gonadotropin)

growth & hormonesSgrade

An FDA-approved hormone that mimics LH, restoring the body's own testosterone and sperm production — the label dates to 1962.

Tesamorelin + Ipamorelin Blend

growth & GHBgrade

A single-vial blend pairing FDA-approved GHRH analog Tesamorelin with the selective ghrelin-agonist Ipamorelin for a combined GH pulse in one injection.

Put the whole protocol
in one place.

Download nowGet Now